Zimmer Biomet beat Q2 estimates and raised its 2025 earnings forecast, driven by strong hip and knee sales, and new product momentum.
Zimmer Biomet beat Q2 estimates and raised its 2025 earnings forecast, driven by strong hip and knee sales, and new product momentum.
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why
A suspected Chinese spy and Singaporean chip deal reveal the Asian networks testing Washington’s grip on AI technology
As the Claude maker prepares to make its Wall Street debut, the FT’s interactive valuation calculator can help readers decide whether the AI giant is
Initia said an attacker exploited compromised cloud credentials to move $3.27 million in crypto assets, with about $2.16 million remaining frozen on its halted network.
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why
Copyright © Louis Velazquez. All Rights Reserved.